A phase II study of 10-propargyl-10-deazaaminopterin (PDX) in patients with advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Pralatrexate (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.